Orbis Medicines

Orbis Medicines is pioneering oral macrocycle drug discovery using its n Gen platform. This platform systematically develops 'n Cycles,' oral macrocycle drugs targeting blockbuster biologic drug targets, offering patients a preferred oral alternative to injectable biologics. The company leverages automated chemistry and machine learning to optimize oral bioavailability.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: €90M

Date: 06-Jan-2025

Investors: NEA, Eli Lilly and Company, Cormorant, the Export and Investment Fund of Denmark, Novo Holdings, Forbion

Markets: Biotechnology, Pharmaceuticals, Therapeutics, Medical, Health Care

HQ: Frederiksberg, Hovedstaden, Denmark

Founded: 2021

Website: https://www.orbismedicines.com/

LinkedIn: https://www.linkedin.com/company/orbismedicines/

Twitter:

Instagram: